Literature DB >> 25417516

Diphtheria outbreak in Thailand, 2012; seroprevalence of diphtheria antibodies among Thai adults and its implications for immunization programs.

Nasamon Wanlapakorn, Pornsak Yoocharoen, Piyanit Tharmaphornpilas, Apiradee Theamboonlers, Yong Poovorawan.   

Abstract

An age distribution shift in diphtheria cases during a 2012 outbreak in northeastern of Thailand suggests adults are increasingly at risk for infection in Thailand. Data regarding immunity against diphtheria among the adult Thai population is limited. We review a 2012 diphtheria outbreak in Thailand and conducted a nationwide seroepidemiological survey to determine the prevalence of diphtheria antibodies among Thai adults in order to inform immunization programs. A total of 41 confirmed cases, 6 probable cases and 101 carriers of diphtheria were reported from northeastern and upper southern Thailand. The diphtheria outbreak in northeastern Thailand occurred among adults aged > or =15 years; sporadic cases occurred among children from upper southern Thailand. We conducted a seroepidemiological survey of 890 Thai adults from 4 age groups (20-29, 30-39, 40-49 and 50-59 years) in 7 different geographical areas of Thailand (Chiang Mai, Ratchaburi, Chon Buri, Nakhon Si Thammarat, Phitsanulok, Khon Kaen and Songkhla). Diptheria toxin antibody levels were measured with a commercially available ELISA test. The seroprotection rate ranged from 83% to 99%, with the highest in eastern Thailand (Chon Buri, 99%) and the lowest in northern Thailand (Chiang Mai, 83%). Diphtheria antibodies declined with increasing age. We recommend one doseof diphtheria-tetanus toxoid (dT) vaccine once after 20 years of age in order to boost the antibody and revaccinations every 10 years to prevent future outbreaks.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25417516

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  8 in total

1.  Respiratory Illness Caused by Corynebacterium diphtheriae and C. ulcerans, and Use of Diphtheria Antitoxin in the United States, 1996-2018.

Authors:  John O Otshudiema; Anna M Acosta; Pamela K Cassiday; Stephen C Hadler; Susan Hariri; Tejpratap S P Tiwari
Journal:  Clin Infect Dis       Date:  2021-11-02       Impact factor: 9.079

2.  The evaluation of anti-diphtheria toxoid antibodies in healthy population in Kon Tum, Vietnam: a population-based study.

Authors:  Tuan Van Le; Van Thi Tuyet Nguyen; Quan Hoang Nguyen; Tram Thi Thu Nguyen; Thuy Thi Ngoc Duong; Trang Thi Thuy Ly; Thanh Ngoc Pham; Vuong Loc Nguyen; Chien Chinh Vien
Journal:  IJID Reg       Date:  2022-04-01

Review 3.  Tetanus-diphtheria-acellular pertussis vaccination for adults: an update.

Authors:  Hyo-Jin Lee; Jung-Hyun Choi
Journal:  Clin Exp Vaccine Res       Date:  2017-01-25

4.  Adverse events following pediatric immunization in an Indian city.

Authors:  Varun Paramkusham; Prashanth Palakurthy; Navya Sri Gurram; Varun Talla; Hunsur Nagendra Vishwas; Venkateshwar Rao Jupally; Satyanarayan Pattnaik
Journal:  Clin Exp Vaccine Res       Date:  2021-09-30

5.  Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination.

Authors:  Nasamon Wanlapakorn; Varisara Ngaovithunvong; Thanunrat Thongmee; Preeyaporn Vichaiwattana; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PLoS One       Date:  2016-02-02       Impact factor: 3.240

6.  Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand.

Authors:  Teeraporn Chinchai; Nawarat Posuwan; Viboonsak Vuthitanachot; Nasamon Wanlapakorn; Yong Poovorawan
Journal:  J Health Popul Nutr       Date:  2019-10-18       Impact factor: 2.000

Review 7.  Whole Genome Sequencing for Surveillance of Diphtheria in Low Incidence Settings.

Authors:  Helena M B Seth-Smith; Adrian Egli
Journal:  Front Public Health       Date:  2019-08-21

8.  Impact of a three-dose diphtheria outbreak response immunization in East Java, Indonesia, 6 months after completion.

Authors:  Dominicus Husada; Dwiyanti Puspitasari; Leny Kartina; Parwati S Basuki; Ismoedijanto Moedjito; Hugeng Susanto; Suradi Suradi; Wiwien Purwitasari; Gito Hartono
Journal:  Hum Vaccin Immunother       Date:  2020-07-21       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.